BGMD Financial Statements From 2010 to 2024
| BGMDDelisted Stock | USD 0.0002 0.00 0.00% |
Check BG Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BG Medicine's main balance sheet or income statement drivers, such as , as well as many indicators such as . BGMD financial statements analysis is a perfect complement when working with BG Medicine Valuation or Volatility modules.
BGMD |
BG Medicine Company Current Valuation Analysis
BG Medicine's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BG Medicine Current Valuation | 545.97 K |
Most of BG Medicine's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BG Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, BG Medicine has a Current Valuation of 545.97 K. This is 100.0% lower than that of the Life Sciences Tools & Services sector and 99.99% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
BG Medicine Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BG Medicine's current stock value. Our valuation model uses many indicators to compare BG Medicine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BG Medicine competition to find correlations between indicators driving BG Medicine's intrinsic value. More Info.BG Medicine is rated below average in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BG Medicine's earnings, one of the primary drivers of an investment's value.About BG Medicine Financial Statements
BG Medicine stakeholders use historical fundamental indicators, such as BG Medicine's revenue or net income, to determine how well the company is positioned to perform in the future. Although BG Medicine investors may analyze each financial statement separately, they are all interrelated. For example, changes in BG Medicine's assets and liabilities are reflected in the revenues and expenses on BG Medicine's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BG Medicine. Please read more on our technical analysis and fundamental analysis pages.
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts. BG MEDICINE operates under Medical Instruments Supplies classification in the United States and is traded on PNK Exchange. It employs 5 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in BGMD Pink Sheet
If you are still planning to invest in BG Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BG Medicine's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |